EUGENE I. DAVIS - 19 Dec 2025 Form 4 Insider Report for WW INTERNATIONAL, INC. (WW)

Role
Director
Signature
/s/ Ashley Chaffin, as Attorney-in-Fact for Eugene I. Davis
Issuer symbol
WW
Transactions as of
19 Dec 2025
Transactions value $
$0
Form type
4
Filing time
22 Dec 2025, 16:01:16 UTC
Previous filing
22 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DAVIS EUGENE I Director 18 WEST 18TH STREET, 7TH FLOOR, NEW YORK /s/ Ashley Chaffin, as Attorney-in-Fact for Eugene I. Davis 22 Dec 2025 0001028689

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WW Deferred Stock Unit Award $0 +1,219 $0.000000 1,219 19 Dec 2025 Common Stock 1,219 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.
F2 This award was granted in connection with the Reporting Person's service as a member of the Issuer's Board of Directors during the third quarter of fiscal 2025.
F3 Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.